Kittika Poonsombudlert
1 clinical trials · Sponsor
◉ Watch Kittika Poonsombudlert
| Record | Firm | Date |
|---|---|---|
| High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) (NCT07177079) | Kittika Poonsombudlert | 2026-03-18 |
Track Kittika Poonsombudlert automatically
Every clearance here is in the API, with alerts when new ones post.